NRx Pharmaceuticals, Inc.
NRXP
Rank in Stocks
#19547
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on... NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.
Share Price
$2.38
Last synced: 2026-11-09
Market Cap
$103.04M
Change (1 day)
0.00%
Change (1 year)
-4.42%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NRx Pharmaceuticals, Inc. (NRXP)
Category
Healthcare
Operating Margin for NRx Pharmaceuticals, Inc. (NRXP)
Operating Margin as of November 2026 TTM: -588.24%
According to NRx Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is -588.24%. At the end of 2025 the company had an operating margin of -1,324.41%.
Operating Margin history for NRx Pharmaceuticals, Inc. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -588.24% | -55.58% |
| 2025 | -1,324.41% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.07% |
US
|
|
| -149.01% | -99.75% |
US
|
|
| 25.57% | -100.04% |
AU
|
|
| 31.23% | -100.05% |
BE
|
|
| 29.35% | -100.05% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about NRx Pharmaceuticals, Inc.'s operating margin
What is NRx Pharmaceuticals, Inc.'s operating margin?
NRx Pharmaceuticals, Inc.'s operating margin is -588.24%, as of Nov 2026.
What was NRx Pharmaceuticals, Inc.'s operating margin in 2025?
In 2025, NRx Pharmaceuticals, Inc.'s operating margin was -1,324.41%, compared with 0.00% in 2024.
How has NRx Pharmaceuticals, Inc.'s operating margin changed since 2020?
From 2020 to 2025, NRx Pharmaceuticals, Inc.'s operating margin was highest in 2024 (0.00%) and lowest in 2025 (-1,324.41%).
How does NRx Pharmaceuticals, Inc.'s operating margin compare with similar companies?
NRx Pharmaceuticals, Inc.'s operating margin (-588.24%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.